MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$5,657K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income/(loss)
Accounts payable and accrued exp...
Depreciation and amortization ex...
Others
Negative Cash Flow Breakdown
Long-term license revenue deferr...
Purchase of property and equipme...
Operating lease liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income/(loss)
27,901
-5,522
-5,940
-5,131
Stock-based compensation expense
118
11
10
109
Depreciation and amortization expenses
432
29
-442
206
Amortization of right-of-use assets
-
191
648
-
Prepaid expenses and other current assets
138
-254
408
-126
Accounts payable and accrued expenses
1,875
-661
997
-1,490
Operating lease liabilities
-176
-172
-154
-145
Long-term license revenue deferred
-35,000
-
-
-
Net cash used in operating activities
-5,179
-5,870
-5,289
-6,325
Purchase of property and equipment
478
2
104
-
Net cash used in investing activities
-478
-2
-104
-
Payments on finance leases
2
3
3
2
Restricted stock units withheld to cover tax obligations
-
-
0
207
Net cash used in financing activities
-2
-3
-3
-209
Effect of foreign currency rates on cash
2
11
6
-
Net change in cash, cash equivalents, and restricted cash
-
-
-
-6,534
Net change in cash, cash equivalents and restricted cash
-5,657
-5,864
-24,895
-
Cash, cash equivalents and restricted cash at beginning of year
42,469
48,333
53,723
73,228
Cash, cash equivalents and restricted cash at end of period
36,812
42,469
48,333
53,723
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Effect of foreign
currency rates on cash
$2K
Net change in cash,
cash equivalents and...
-$5,657K
Canceled cashflow
$2K
Net income/(loss)
$27,901K
(222.29%↑ Y/Y)
Accounts payable and
accrued expenses
$1,875K
(1175.51%↑ Y/Y)
Depreciation and
amortization expenses
$432K
(5.62%↑ Y/Y)
Stock-based compensation
expense
$118K
(-98.70%↓ Y/Y)
Net cash used in
operating activities
-$5,179K
(60.06%↑ Y/Y)
Net cash used in
investing activities
-$478K
Canceled cashflow
$30,326K
Net cash used in
financing activities
-$2K
(60.00%↑ Y/Y)
Long-term license revenue
deferred
-$35,000K
Purchase of property and
equipment
$478K
Operating lease
liabilities
-$176K
(36.69%↑ Y/Y)
Prepaid expenses and
other current assets
$138K
(127.54%↑ Y/Y)
Payments on finance
leases
$2K
(-60.00%↓ Y/Y)
Buy us a coffee
Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals, Inc. (ATNM)